WellDyne Receives 2022 PBMI Excellence Award

Congratulations WellDyne! The 2022 PBMI Excellence Award for Care Management Strategies recognizes the highly effective WellManaged Diabetes program that promotes optimal health and reduced costs. Accepting the award on behalf of WellDyne were Nick Page, Chief Clinical & Strategy Officer and David Skomo, Chief Operating Officer.

“We are honored to have earned this national recognition,” says Dave. “While the award focuses on our diabetes program, it actually encapsulates our overall care management philosophy spanning many challenging, chronic conditions.”

With 60% of Americans living with a chronic condition, the need for highly targeted, effective and flexible clinical care has never been greater. The WellDyne approach leverages technology, clinical expertise, relationships, engagement, and education to create a holistic view of each patient.

“Through our expertise and data, we drive the right intensity of service and engagement, rather than lumping all patients together into one strategy,” explains Nick. “Using a flexible feedback loop, we encourage patients to take an active role in their care and as a result, we have 22% lower insulin utilization because patients need less insulin to manage their diabetes.”

Since 2016, the PBMI Excellence Awards have singled out organizations for groundbreaking strategies that address specific challenges within the industry. Winning organizations are recognized for developing best-in-class strategies to address the challenges of drug cost management, quality improvement and care management. All submissions for the award were reviewed and scored by the PBMI® Excellence Award evaluation panel, then further ranked based on their contribution to improving outcomes and/or processes.